Global Molecular Quality Controls Market, Forecast 2028
Bharat Book Bureau Provides the Trending Market Research Report on Molecular Quality Controls Market Product, Application, Analyte type, End User…
Stay updated with breaking news from Molbio Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bharat Book Bureau Provides the Trending Market Research Report on Molecular Quality Controls Market Product, Application, Analyte type, End User…
/PRNewswire/ -- The molecular quality controls industry is set to witness significant growth and advancements in the near future. With the increasing demand...
Integrated electronic manufacturing services provider Cyient DLM made a strong debut on the stock exchanges, with shares listing at a premium of 52% over the IPO issue price of Rs 265 on NSE. The company's IPO received a massive response from investors with an overall subscription at 71.3 times. Cyient DLM will use the net proceeds from the issue to fund incremental working capital requirements, capital expenditure, repayment of debt and other general corporate purposes.
"We continue to advise allotted investors to book profits, and if anyone wishes to buy, they should wait and watch for the counter as markets may see some pressure to sustain at higher levels," Tapse said.
The grey market premium (GMP) of Cyient DLM is around Rs 150-155 in the unlisted market. If we consider the upper price band of Rs 265, the company's shares are expected to list at a premium of 58%.